[Fluticasone propionate, corticosteroid for topical treatment].
The aim of this study was to evaluate the usefulness of fluticasone propionate in various dermatoses and to present the data to non-dermatologists. The study was performed at the Department of Dermatology, University School of Medicine in Poznań. The studied group consisted of 40 cases of various types of eczema, psoriasis vulgaris, DLE, photodermatoses and morphea. Fluticasone propionate cream or ointment was applied to lesional skin twice daily for 7-19 days. Acute eczematous skin lesions significantly improved after the first seven days of treatment, whereas in patients with chronic eczema the good therapeutic results were observed after 14-19 days. Fluticasone propionate was also effective in the treatment of DLE and photodermatoses.
Neumann
E
E
Katedry i Kliniki Dermatologii Akademii Medycznej w Poznaniu.
Raszeja-Kotelba
B
B
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D000730:Androstadienes / Q000008:administration & dosage*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D004485:Eczema / Q000188:drug therapy; D005260:Female; D000068298:Fluticasone; D005938:Glucocorticoids; D006801:Humans; D008297:Male; D008875:Middle Aged; D010787:Photosensitivity Disorders / Q000188:drug therapy; D011512:Proteus Infections / Q000188:drug therapy; D011514:Proteus vulgaris; D011565:Psoriasis / Q000188:drug therapy; D012594:Scleroderma, Localized / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*
D000730:Androstadienes; D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D000068298:Fluticasone
Propionian flutikazonu, kortykosteroid do stosowania miejscowego.